2-48620875-G-C
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_006872.5(GTF2A1L):c.46G>C(p.Glu16Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000032 in 1,594,108 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006872.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTF2A1L | NM_006872.5 | c.46G>C | p.Glu16Gln | missense_variant | Exon 2 of 9 | ENST00000403751.8 | NP_006863.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTF2A1L | ENST00000403751.8 | c.46G>C | p.Glu16Gln | missense_variant | Exon 2 of 9 | 1 | NM_006872.5 | ENSP00000384597.3 | ||
STON1-GTF2A1L | ENST00000394754.5 | c.2158G>C | p.Glu720Gln | missense_variant | Exon 4 of 11 | 1 | ENSP00000378236.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152036Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000418 AC: 10AN: 238956 AF XY: 0.0000693 show subpopulations
GnomAD4 exome AF: 0.0000319 AC: 46AN: 1441954Hom.: 3 Cov.: 31 AF XY: 0.0000391 AC XY: 28AN XY: 716836 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74404 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.46G>C (p.E16Q) alteration is located in exon 2 (coding exon 2) of the GTF2A1L gene. This alteration results from a G to C substitution at nucleotide position 46, causing the glutamic acid (E) at amino acid position 16 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at